Annual report pursuant to Section 13 and 15(d)

Stock-Based Compensation (Tables)

v3.24.0.1
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of fair value weighted-average assumptions
The following table presents, on a weighted average basis, the assumptions used in the Black-Scholes option-pricing model to determine the grant-date fair value of stock options granted during the years ended December 31, 2023 and 2022:
Year Ended December 31,
2023 2022
Risk-free interest rate 4.2  % 1.6  %
Expected term (in years) 6.1 6.1
Expected volatility 87.5  % 75.0  %
Expected dividend yield 0.0  % 0.0  %
Summary of stock option activity
The following tables summarize the Company’s stock option activity under the 2021 Equity Incentive Plan (in thousands, except for share and per share data):
Number of
Shares
Weighted
Average
Exercise Price
Weighted
Average
Remaining
Contractual Term (in years)
Aggregate
Intrinsic Value
Outstanding as of December 31, 2021
20,769,130 $ 0.39 
Granted 2,262,925 3.49 
Exercised (1,896,975) 0.43 
Forfeited (710,707) 0.42 
Expired (27,549) 0.42 
Outstanding as of December 31, 2022
20,396,824 $ 0.73 
Granted 2,840,421 3.12 
Exercised (1,735,978) 0.38 
Forfeited (1,164,932) 1.72 
Expired (11,807) 0.42 
Outstanding as of December 31, 2023
20,324,528 $ 1.04  6.0 $ 74,768 
Vested and expected to vest as of December 31, 2023
20,324,528 $ 1.04  6.0 $ 74,768 
Options exercisable as of December 31, 2023
16,114,401 $ 0.67  5.4 $ 65,339 
Summary of restricted stock unit activity
The following table summarizes the Company’s restricted stock units activity under its existing restricted stock unit plan:
Number of
Shares
Grant Date Fair
Value
Outstanding as of December 31, 2021
1,951,924 $ 6.76 
Granted 7,613,472 3.26 
Vested (565,774) 6.72 
Forfeited (1,497,677) 5.15 
Outstanding as of December 31, 2022
7,501,945 $ 3.54 
Granted 9,477,014 3.48 
Vested (2,833,155) 3.55 
Forfeited (1,099,125) 3.54 
Outstanding as of December 31, 2023
13,046,679 $ 3.49 
Schedule of performance shares
The following table summarizes the Company's performance stock units activity under its existing performance stock units plan:
Number of
Shares
Grant Date Fair
Value
Outstanding as of December 31, 2021
—  $ — 
Granted 947,000  2.65 
Vested —  — 
Forfeited (83,000) 2.65 
Outstanding as of December 31, 2022
864,000  $ 2.65 
Granted —  — 
Vested (432,000) 2.65 
Forfeited (52,000) 2.67 
Outstanding as of December 31, 2023
380,000  $ 2.64 
Schedule of fair value measurements of common stock warrants granted
The Company utilized a Black-Scholes pricing model to determine the grant-date fair value of the Finback Common Stock Warrants. The assumptions used are presented in the following table:
Warrants - Black Scholes
Risk-free interest rate 0.4  %
Expected term (in years) 3.0
Expected volatility 23.9  %
Expected dividend yield —  %
Schedule of allocation of share based compensation expense
Stock-based compensation expense was classified in the consolidated statements of operations and comprehensive loss as follows (in thousands):
Year Ended December 31,
2023 2022
Cost of revenue $ 583 $ 829
Research and development 4,284 4,009
Sales and marketing 9,387 10,038
General and administrative 9,897 7,622
Total stock-based compensation expense $ 24,151 $ 22,498
Schedule of stock-based compensation expense
Stock-based compensation expense by award type recognized in the consolidated statements of operations and comprehensive loss was as follows (in thousands):
Year Ended December 31,
2023 2022
Stock options $ 2,925 $ 1,594
Earn-out shares 2,073 6,499
Warrants 3,147 4,523
RSUs and PSUs 16,006 9,882
Total stock-based compensation expense $ 24,151 $ 22,498